Otto W - Search Results

1

Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts.

Sikic D, Wirtz RM, Wach S, Dyrskjøt L, Erben P, Bolenz C, Breyer J, Otto W, Hoadley KA, Lerner SP, Eckstein M, Hartmann A, Keck B. Sikic D, et al. Among authors: otto w. Transl Oncol. 2019 Apr;12(4):661-668. doi: 10.1016/j.tranon.2019.01.005. Epub 2019 Mar 2. Transl Oncol. 2019. PMID: 30831560 Free PMC article.

2

Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?

Denzinger S, Otto W, Burger M, Hammerschmied C, Junker K, Hartmann A, Wieland WF, Walter B. Denzinger S, et al. Among authors: otto w. World J Surg Oncol. 2007 Feb 5;5:16. doi: 10.1186/1477-7819-5-16. World J Surg Oncol. 2007. PMID: 17280613 Free PMC article.

3

Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients.

Denzinger S, Otto W, Fritsche HM, Roessler W, Wieland WF, Hartmann A, Burger M. Denzinger S, et al. Among authors: otto w. Int J Urol. 2007 Nov;14(11):995-9; discussion 999. doi: 10.1111/j.1442-2042.2007.01890.x. Int J Urol. 2007. PMID: 17956523

4

Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder.

Denzinger S, Burger M, Fritsche HM, Bertz S, Hofstädter F, Wieland WF, Hartmann A, Otto W. Denzinger S, et al. Among authors: otto w. Scand J Urol Nephrol. 2009;43(4):282-7. doi: 10.1080/00365590902854354. Scand J Urol Nephrol. 2009. PMID: 19382004

5

No mutations of FGFR3 in normal urothelium in the vicinity of urothelial carcinoma of the bladder harbouring activating FGFR3 mutations in patients with bladder cancer.

Otto W, Denzinger S, Bertz S, Gaumann A, Wild PJ, Hartmann A, Stoehr R. Otto W, et al. Int J Cancer. 2009 Nov 1;125(9):2205-8. doi: 10.1002/ijc.24598. Int J Cancer. 2009. PMID: 19621447 Free article.

6

Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort.

Fritsche HM, Burger M, Svatek RS, Jeldres C, Karakiewicz PI, Novara G, Skinner E, Denzinger S, Fradet Y, Isbarn H, Bastian PJ, Volkmer BG, Montorsi F, Kassouf W, Tilki D, Otto W, Capitanio U, Izawa JI, Ficarra V, Lerner S, Sagalowsky AI, Schoenberg M, Kamat A, Dinney CP, Lotan Y, Shariat SF. Fritsche HM, et al. Among authors: otto w. Eur Urol. 2010 Feb;57(2):300-9. doi: 10.1016/j.eururo.2009.09.024. Epub 2009 Sep 12. Eur Urol. 2010. PMID: 19766384

7

Prognostic factors of papillary renal cell carcinoma: results from a multi-institutional series after pathological review.

Herrmann E, Trojan L, Becker F, Wülfing C, Schrader AJ, Barth P, Stöckle M, Hammerschmied CG, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Legal W, Wullich B, Bolenz C, Klein T, Noldus J, Bierer S, Hertle L, Brenner W, Roos F, Michel MS, Walter B, Wieland W, Gerss J, Otto W, Hartmann A. Herrmann E, et al. Among authors: otto w. J Urol. 2010 Feb;183(2):460-6. doi: 10.1016/j.juro.2009.10.026. Epub 2009 Dec 14. J Urol. 2010. PMID: 20006851

8

The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer.

Otto W, Denzinger S, Fritsche HM, Burger M, Wieland WF, Hofstädter F, Hartmann A, Bertz S. Otto W, et al. BJU Int. 2011 Feb;107(3):404-8. doi: 10.1111/j.1464-410X.2010.09515.x. Epub 2010 Aug 12. BJU Int. 2011. PMID: 20707791 Review.

9

Multicolor FISH (UroVysion) facilitates follow-up of patients with high-grade urothelial carcinoma of the bladder.

Fritsche HM, Burger M, Dietmaier W, Denzinger S, Bach E, Otto W, Doblinger M, Schwarz S, Buchner H, Hartmann A. Fritsche HM, et al. Among authors: otto w. Am J Clin Pathol. 2010 Oct;134(4):597-603. doi: 10.1309/AJCPKKWBDSAOZ4RW. Am J Clin Pathol. 2010. PMID: 20855641

10

Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.

Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF. Fritsche HM, et al. Among authors: otto w. Urol Oncol. 2012 Sep;30(5):666-72. doi: 10.1016/j.urolonc.2010.07.010. Epub 2010 Oct 8. Urol Oncol. 2012. PMID: 20933445

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

502 results

Search Page